Related Experiment Video
Updated: Aug 24, 2026

Molecular Entanglement and Electrospinnability of Biopolymers
Published on: September 3, 2014
Changes in blood viscosity with mucopolysaccharide polysulfate
Masahito Hitosugi1, Kazunobu Omura, Masahito Kido
1Department of Legal Medicine, Dokkyo University School of Medicine, Tochigi, Japan. hitosugi@dokkyomed.ac.jp
Abstract:
We examined the dose-dependent effects of mucopolysaccharide polysulfate (MPS) on coagulation variables and whole-blood viscosity in human blood. Both 0.01% and 0.1% MPS significantly reduced levels of both fibrin monomer and thrombin-antithrombin III complex in a manner similar to that of 2.0 IU/ml heparin sodium. Furthermore, MPS dose-dependently decreased whole-blood viscosity, as measured with an oscillation viscometer. Because MPS can be applied in creams and gels, percutaneous application of MPS may effectively reduce whole-blood viscosity in local veins.
Insights
Mucopolysaccharide polysulfate (MPS) effectively reduces blood clotting factors and viscosity in a dose-dependent manner, similar to heparin. Topical application may improve local blood flow.
Area of Science:
- Biochemistry
- Hematology
- Pharmacology
Background:
- Blood viscosity and coagulation are critical factors in circulatory health.
- Mucopolysaccharide polysulfate (MPS) is a substance with potential anticoagulant properties.
- Understanding MPS's effects on coagulation and viscosity is essential for therapeutic applications.
Purpose of the Study:
- To investigate the dose-dependent effects of MPS on human blood coagulation.
- To assess the impact of MPS on whole-blood viscosity.
- To compare MPS's efficacy with heparin sodium.
Main Methods:
- Human blood samples were treated with varying concentrations of MPS (0.01% and 0.1%).
- Coagulation variables, including fibrin monomer and thrombin-antithrombin III complex, were measured.
- Whole-blood viscosity was determined using an oscillation viscometer.
- Comparisons were made with heparin sodium (2.0 IU/ml).
Main Results:
- MPS significantly reduced fibrin monomer and thrombin-antithrombin III complex levels at both tested concentrations.
- The anticoagulant effect of MPS was comparable to that of heparin sodium.
- MPS demonstrated a dose-dependent decrease in whole-blood viscosity.
- Higher concentrations of MPS led to greater reductions in viscosity.
Conclusions:
- Mucopolysaccharide polysulfate exhibits significant dose-dependent anticoagulant and viscosity-reducing effects in human blood.
- MPS shows comparable efficacy to heparin sodium in inhibiting key coagulation markers.
- Percutaneous application of MPS, potentially via creams or gels, may offer a viable strategy for reducing local whole-blood viscosity and improving venous blood flow.
Related Concept Videos
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Determination of Molar Masses of Polymers II
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Viscosity
The SI unit of viscosity is...

